Product Name

Molecular Formula

Sequence

LWamide III (Potential)

C₂₉H₄₁N₇O₇

QPGLW

LWS neuropeptide

C₃₉H₅₉N₉O₁₀

KPPSLWS

LTX-315

C₇₈H₁₀₆N₁₈O₉

K-K-W-W-K-K-W-Dip-K-NH2

LTVSPWY

C₄₃H₆₀N₈O₁₁

H-LTVSPWY-OH

LSer-PCecL5

HHHLFGHVGHEVERSLHKVGHKLEHACHEVHKTAKKVQK

LSer-Cec6

GWLKKFGKKIERVGQHTRDATIQAIGVAQQAANVAATLKG

LSer-Cec5

GLVKKIGKKIERVGQHTRDASIQAIGIAQQAANVAATARG

LSer-Cec4

GWLKKIGKKIERVGQHTRDASIQAIGIAQQAANVAATARG

LSer-Cec3

GWLKKIGKKIERVGQHTRDATIQVLGVAQQAANVAATARG

LSer-Cec2

GWLRDFGKRIERVGQHTRDATIQAIGVAQQAANVAATVRG

LSer-Cec1

GWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG

LS-stomoxyn

C₁₉₃H₃₃₁N₅₉O₅₁S

H-GFRKRFNKLVKKVKHTIKETANVSKDVAIVAGSGVAVGAAM-NH2

LS-sarcotoxin

C₁₈₅H₃₁₇N₅₉O₅₂

H-GWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLK-NH2

LRRKtide

C₈₃H₁₄₇N₃₁O₂₂

H-RLGRDKYKTLRQIRQ-OH

LRNLRFamide

C₃₇H₆₃N₁₃O₈

LRNLRF

LRELHLNNN

C₄₇H₇₉N₁₇O₁₅

H-LRELHLNNN-OH

LQEQ-19 (mouse, rat)

C₁₀₆H₁₆₅N₂₉O₃₄

LQEQEELENYIEHVLLHRP

LQEQ-19 (human)

C₁₀₆H₁₇₀N₃₀O₃₄

LQEQEELENYIEHVLLRRP

LQEQ-19

C₁₀₆H₁₆₆N₃₀O₃₃

LQEQEELENYIEHVLLHRP

LPCL

C₂₀H₃₆N₄O₅S

H-LPCL-OH

LP1A

QRFSQPTFKLPQGRLTLSRKF

LNPFLRFamide

C₄₅H₆₇N₁₁O₉

LNPFLRF

LMWP - Low molecular weight protamine

C₇₂H₁₄₂N₄₄O₁₆

VSRRRRRRGGRRRR

LMWP

C₇₅H₁₄₇N₄₅O₁₇S

H-CVSRRRRRRGGRRRR-OH

LLO190

C₆₁H₉₀N₁₆O₂₁

H-NEKYAQAYPNVS-OH

LLIYDTSK

C₄₄H₇₃N₉O₁₄

H-LLIYDTSK-OH

LL-37, reverse sequence

C₂₀₅H₃₄₀N₆₀O₅₃

SETRPVLNRLFDKIRQVIRKFEKGIKEKSKRFFDGLL

LL-37 pentamide

C₂₀₈H₃₄₃N₆₅O₄₈

LLGNFFRKSKQKIGKQFKRIVQRIKNFFRNLVPRTQS

LL-23

LLGDFFRKSKEKIGKEFKRIVQR

LL 37 (18-37) (human)

C₁₀₉H₁₉₀N₃₆O₂₉

H-KRIVQRIKDFLRNLVPRTES-OH

LITGLW

C₃₅H₅₅N₇O₈

H-LITGLW-OH

LIP2 (human)

C₁₈₄H₂₈₈N₅₈O₅₈

LRSPRVLFSTQPPREAADTQDLDFEVGGAAPFNRTHRS

LIP1 (human)

C₁₃₃H₂₂₉N₄₅O₃₇

ARSAPAAAIAARVAGQTRNITVDPRLFKK

LIH383

C₄₅H₇₂N₁₆O₈S

H-FGGFMRRK-NH2

LHRH/GnRH

C₅₅H₇₅N₁₇O₁₃

Pyr-HWSYGLRPG-NH2

LHRH-II

C₅₈H₆₇N₁₅O₁₄

EHWSHGWYP

LFRFamide neuropeptide

C₃₆H₅₃N₁₁O₇

H-GNLFRF-NH2

LFB

C₁₄₅H₂₅₂N₄₀O₄₂S₂

H-GLFSVVKGVLKGVGKNVSGSLLDQLKCKISGGC-OH

LF11-322

C₆₁H₉₉N₂₃O₉

H-PFWRIRIRR-NH2

LF11-227

C₆₄H₈₉N₂₃O₈

H-FWRRFWRR-NH2